Genome-scale gene expression analysis is rapidly changing how we study, diagnose and treat human cancers. In order to meet the scientific needs of Cancer Center investigators for gene expression analyses, the Gene- Expression Shared Facility was established in early 2004. The facility provides support to Cancer Center investigators interested in microarray technology. The facility was recently established using Cancer Center developmental funds and is focused primarily on the study of gene expression analyses as they relate to human malignancy. The facility includes both Affymetrix and spotted array technologies and has incorporated into it a strong bioinformatics network to support the facility. Real-time quantitative PCR analysis has been included in order to provide a rapid method to validate hits from microarray experiments. The Shared Facility has been designed specifically to: 1) provide a comprehensive facility for global-scale gene expression studies with a emphasis on human malignancies; 2) provide a broad range of services in order to meet the scientific needs of a variety of Cancer Center investigators including basic researchers and clinicians; 3) work closely with the Biostatistics and Bioinformatics Shared Facility to provide investigators with experimental design, data analysis and data interpretation support; 4) educate investigators and work to increase knowledge and understanding of microarray technology in order to most appropriately utilize the technologies. The facility provides full support including experimental design, RNA purification, probe synthesis, array hybridizations, data acquisition and storage, and full bioinformatics support. The facility is staffed by two Co-directors, two technical staff and a bioinformatics specialist.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA013148-36
Application #
7414806
Study Section
Subcommittee G - Education (NCI)
Project Start
2007-05-01
Project End
2010-03-31
Budget Start
2007-05-01
Budget End
2008-03-31
Support Year
36
Fiscal Year
2007
Total Cost
$111,115
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Carson, Tiffany L; Wang, Fuchenchu; Cui, Xiangqin et al. (2018) Associations Between Race, Perceived Psychological Stress, and the Gut Microbiota in a Sample of Generally Healthy Black and White Women: A Pilot Study on the Role of Race and Perceived Psychological Stress. Psychosom Med 80:640-648
Williams, Adele P; Waters, Alicia M; Stewart, Jerry E et al. (2018) A novel retinoid X receptor agonist, UAB30, inhibits rhabdomyosarcoma cells in vitro. J Surg Res 228:54-62
Frugé, Andrew D; Cases, Mallory G; Howell, Carrie R et al. (2018) Fingernail and toenail clippings as a non-invasive measure of chronic cortisol levels in adult cancer survivors. Cancer Causes Control 29:185-191
McCaw, Tyler R; Randall, Troy D; Arend, Rebecca C (2018) Overcoming immune suppression with epigenetic modification in ovarian cancer. Transl Res :
Geng, Mengxin; Austin, Frank; Shin, Ronald et al. (2018) Covalent Structure and Bioactivity of the Type AII Lantibiotic Salivaricin A2. Appl Environ Microbiol 84:
Samykutty, Abhilash; Grizzle, William E; Fouts, Benjamin L et al. (2018) Optoacoustic imaging identifies ovarian cancer using a microenvironment targeted theranostic wormhole mesoporous silica nanoparticle. Biomaterials 182:114-126
Friedman, Gregory K; Bernstock, Joshua D; Chen, Dongquan et al. (2018) Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression. Sci Rep 8:13930
Powell, T Clark; Dilley, Sarah E; Bae, Sejong et al. (2018) The Impact of Racial, Geographic, and Socioeconomic Risk Factors on the Development of Advanced-Stage Cervical Cancer. J Low Genit Tract Dis 22:269-273
Kasten, Benjamin B; Oliver, Patsy G; Kim, Harrison et al. (2018) 212Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models. Int J Mol Sci 19:
Subramaniam, Akila; Blanchard, Christina T; Erickson, Britt K et al. (2018) Feasibility of Complete Salpingectomy Compared With Standard Postpartum Tubal Ligation at Cesarean Delivery: A Randomized Controlled Trial. Obstet Gynecol 132:20-27

Showing the most recent 10 out of 747 publications